Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (5.137)

1

CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells

enthalten in: Cancer biology & therapy | 2024

von Wang, H. | Koob, T. | Fromm, J. | +3

2

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

enthalten in: The New England journal of medicine | 2024

von Powles, T. | Valderrama, B. | Gupta, S. | +122

3

Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors

enthalten in: Clinical and translational science | 2024

von Robbrecht, D. | Grob, J. | Bechter, O. | +20

4

A phase Ib study evaluating the safety and efficacy of IBI310 plus sintilimab in patients with advanced non-small-cell lung cancer who have progressed after anti-PD-1/L1 therapy

enthalten in: Cancer medicine | 2024

von Zhao, Y. | Chen, X. | Yao, J. | +12

5

Case report outcome of cetuximab treatment in a metastatic colorectal cancer patient with novel KRAS P34R

enthalten in: Anti-cancer drugs | 2024

von Chen, R. | Yang, D. | Liu, Y. | +2

6

Neutropaenia complications from Ocrelizumab and Rituximab treatment

enthalten in: Multiple sclerosis and related disorders | 2024

von Pang, V. | Seery, N. | Wesselingh, R. | +17

7

Transfusion management in the era of magrolimab (Hu5F9-G4), an anti-CD47 monoclonal antibody therapy

enthalten in: Transfusion | 2023

von Singh, N. | Staves, J. | Storry, J. | +6

8

Anti-EGFR Antibodies in the Management of Advanced Colorectal Cancer

enthalten in: The oncologist | 2023

von Kasi, P. | Afable, M. | Herting, C. | +2

9

Pembrolizumab in mCRPC - Combination therapies as breakthrough to success?

enthalten in: Current opinion in urology | 2023

von Plas, S. | Pircher, A. | Heidegger, I.

10

Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors : A Phase 1a/1b Nonrandomized Controlled Trial

enthalten in: JAMA oncology | 2023

von Kim, T. | Bedard, P. | LoRusso, P. | +21

CommentOn: JAMA Oncol. 2023 Nov 1;9(11):1503-1504. - PMID 37768657

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[514]